398 related articles for article (PubMed ID: 15585867)
1. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism.
Stockinger S; Reutterer B; Schaljo B; Schellack C; Brunner S; Materna T; Yamamoto M; Akira S; Taniguchi T; Murray PJ; Müller M; Decker T
J Immunol; 2004 Dec; 173(12):7416-25. PubMed ID: 15585867
[TBL] [Abstract][Full Text] [Related]
2. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling.
Rothfuchs AG; Trumstedt C; Wigzell H; Rottenberg ME
J Immunol; 2004 May; 172(10):6345-53. PubMed ID: 15128825
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.
Zhai Y; Shen XD; O'Connell R; Gao F; Lassman C; Busuttil RW; Cheng G; Kupiec-Weglinski JW
J Immunol; 2004 Dec; 173(12):7115-9. PubMed ID: 15585830
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
[TBL] [Abstract][Full Text] [Related]
5. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity.
Edelson BT; Unanue ER
J Immunol; 2002 Oct; 169(7):3869-75. PubMed ID: 12244184
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
[TBL] [Abstract][Full Text] [Related]
7. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate toll-like receptor signaling in innate immune cells.
Baetz A; Frey M; Heeg K; Dalpke AH
J Biol Chem; 2004 Dec; 279(52):54708-15. PubMed ID: 15491991
[TBL] [Abstract][Full Text] [Related]
8. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms.
Fortune SM; Solache A; Jaeger A; Hill PJ; Belisle JT; Bloom BR; Rubin EJ; Ernst JD
J Immunol; 2004 May; 172(10):6272-80. PubMed ID: 15128816
[TBL] [Abstract][Full Text] [Related]
10. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
11. Viral activation of macrophages through TLR-dependent and -independent pathways.
Malmgaard L; Melchjorsen J; Bowie AG; Mogensen SC; Paludan SR
J Immunol; 2004 Dec; 173(11):6890-8. PubMed ID: 15557184
[TBL] [Abstract][Full Text] [Related]
12. IFN-alpha regulates TLR-dependent gene expression of IFN-alpha, IFN-beta, IL-28, and IL-29.
Sirén J; Pirhonen J; Julkunen I; Matikainen S
J Immunol; 2005 Feb; 174(4):1932-7. PubMed ID: 15699120
[TBL] [Abstract][Full Text] [Related]
13. Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling.
Sato S; Sugiyama M; Yamamoto M; Watanabe Y; Kawai T; Takeda K; Akira S
J Immunol; 2003 Oct; 171(8):4304-10. PubMed ID: 14530355
[TBL] [Abstract][Full Text] [Related]
14. Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways.
Henneke P; Takeuchi O; Malley R; Lien E; Ingalls RR; Freeman MW; Mayadas T; Nizet V; Akira S; Kasper DL; Golenbock DT
J Immunol; 2002 Oct; 169(7):3970-7. PubMed ID: 12244198
[TBL] [Abstract][Full Text] [Related]
15. Differential involvement of IFN-beta in Toll-like receptor-stimulated dendritic cell activation.
Hoshino K; Kaisho T; Iwabe T; Takeuchi O; Akira S
Int Immunol; 2002 Oct; 14(10):1225-31. PubMed ID: 12356687
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
17. Early alpha/beta interferon production by myeloid dendritic cells in response to UV-inactivated virus requires viral entry and interferon regulatory factor 3 but not MyD88.
Hidmark AS; McInerney GM; Nordström EK; Douagi I; Werner KM; Liljeström P; Karlsson Hedestam GB
J Virol; 2005 Aug; 79(16):10376-85. PubMed ID: 16051830
[TBL] [Abstract][Full Text] [Related]
18. Antagonism between MyD88- and TRIF-dependent signals in B7RP-1 up-regulation.
Zhou Z; Hoebe K; Du X; Jiang Z; Shamel L; Beutler B
Eur J Immunol; 2005 Jun; 35(6):1918-27. PubMed ID: 15884053
[TBL] [Abstract][Full Text] [Related]
19. Gene expression and antiviral activity of alpha/beta interferons and interleukin-29 in virus-infected human myeloid dendritic cells.
Osterlund P; Veckman V; Sirén J; Klucher KM; Hiscott J; Matikainen S; Julkunen I
J Virol; 2005 Aug; 79(15):9608-17. PubMed ID: 16014923
[TBL] [Abstract][Full Text] [Related]
20. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice.
Seki E; Tsutsui H; Tsuji NM; Hayashi N; Adachi K; Nakano H; Futatsugi-Yumikura S; Takeuchi O; Hoshino K; Akira S; Fujimoto J; Nakanishi K
J Immunol; 2002 Oct; 169(7):3863-8. PubMed ID: 12244183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
